Albany Medical College

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Albany Medical College sits in the top decile of US sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count).

52 total trials 7 currently recruiting 35 completed later-stage tilt top decile by trial count

Albany Medical College: 52 sponsored US clinical trials, 7 recruiting.

Albany Medical College sponsors 52 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 35 completed. 15 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.

Top-decile sponsor footprint

Albany Medical College ranks in the top decile of sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

35 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

52 total, page 1 of 2

RECRUITING NA

DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs

NCT07419360

RECRUITING NA

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

NCT06517901

RECRUITING NA

Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED

NCT06668766

RECRUITING NA

Impact of Patient Selected Visual Art in the Hospital Room During Antepartum Admission on Hospital Satisfaction Scores and Patient Experience

NCT06790043

RECRUITING NA

Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients

NCT06677541

RECRUITING NA

Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children

NCT06135311

RECRUITING Phase 4

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

NCT05629494

NOT YET RECRUITING Phase 2

Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients

NCT07670507

COMPLETED

Predictors of Measles Vaccine Hesitancy in New York State

NCT07373093

TERMINATED NA

Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi

NCT05869890

COMPLETED NA

Intraoperative Neuromonitoring Recording With a Novel SCS Paddle: Phase II

NCT05459324

COMPLETED Phase 4

The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches

NCT06901518

TERMINATED NA

Dilapan-S® for Induction of Labor The Feasibility Study

NCT04521062

COMPLETED NA

Alternative Blood Pressure Measurements in OB Patients

NCT04291365

COMPLETED NA

TENS Treatment for Bedwetting

NCT04313192

COMPLETED NA

Intraoperative Neuromonitoring Recording With a Novel SCS Paddle

NCT05045625

COMPLETED NA

Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications

NCT04081636

TERMINATED Phase 4

Acute Control of Chronic Hypertension

NCT03877692

TERMINATED Phase 4

Acute Labetalol Use in Preeclampsia

NCT03872336

COMPLETED NA

The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty

NCT04112407

COMPLETED Phase 4

Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy

NCT03701919

TERMINATED

The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy

NCT03835039

COMPLETED NA

No Opioids PrescrIptions On Discharge After Surgery

NCT04469868

COMPLETED NA

OPIOID Study - Pain With Osmotic Dilators

NCT03710239

COMPLETED

Glans Size in Hypospadias Compared to Normal

NCT03593720

TERMINATED Phase 4

Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

NCT03453541

TERMINATED Phase 4

Effect of Gabapentin on Postoperative Opioid Analgesic Use and Pain in Adolescents Undergoing Tonsillectomy

NCT05024825

COMPLETED

Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications

NCT03289390

COMPLETED NA

Stimulation Change Effects on Quantitative Sensory Testing in Neuromodulation Patients

NCT04708392

COMPLETED NA

Aromatherapy as Treatment for n/v of Pregnancy

NCT03609567

COMPLETED NA

IV Acetaminophen and Patent Ductus Arteriosus

NCT03008876

TERMINATED

Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

NCT03026192

COMPLETED Phase 4

Ziconotide as First-Line IDT

NCT03321955

COMPLETED

Allergy Testing of Patients Labeled as Penicillin Allergic

NCT02983630

COMPLETED NA

Decreasing Patient Dissatisfaction With Unplanned Cesarean Sections

NCT02472327

COMPLETED NA

Hemodialysis Access Surveillance Evaluation Study

NCT02376361

COMPLETED Phase 4

Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate

NCT02340000

TERMINATED Phase 4

Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome

NCT02164734

COMPLETED Phase 4

Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis

NCT02651324

COMPLETED Phase 3

Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia

NCT01605864

COMPLETED

Do Elevated BNP Levels Predict Hemodynamically Significant PDAs

NCT01497054

COMPLETED NA

The Effect of Timing of Removal of Wound Dressing on Surgical Site Infection Rate After Cesarean Delivery

NCT02902419

COMPLETED NA

Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge

NCT01374295

COMPLETED NA

Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls

NCT01379716

COMPLETED

The Effects of Patient Features on Opioid Induced End-Tidal CO2

NCT01371903

COMPLETED NA

Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia

NCT01127490

COMPLETED Phase 4

Study of Fibromyalgia Treated With Milnacipran

NCT01125423

COMPLETED

Cohort Comparison of Dental Nerve Block With Other Forms of Analgesia in Alleviating the Pain of Toothache

NCT01268436

COMPLETED Phase 4

Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation

NCT01042600

COMPLETED Phase 2

Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy

NCT01086150

Page 1 of 2 Next →

Where Albany Medical College enrollment is open (later-stage tilt)

7 recruiting of 52 indexed (13% open); 35 completed (67%).

Phase mix: 15 late (III/IV) vs 3 early (I/II) (later-stage heavy).

Top condition: Prostate Cancer (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Albany Medical College: open-pipeline peers nationwide

Peers matched on 52 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

Albany Medical College sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15% Total trials Recruiting share Albany Medical CollegeBurzynski Research InstituteDr. Reddy's Laboratories LimitedPTC TherapeuticsSpectrum PharmaceuticalsTaiho OncologyUniversity of MichiganWayne State UniversityCase Comprehensive Cancer Center
Albany Medical College sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Albany Medical College sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 52 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this Albany Medical College page

52 registered trials is a research-attention snapshot, not an endorsement of Albany Medical College or any single study.

  • 7 of Albany Medical College's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition Albany Medical College studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Albany Medical College pipeline card: 52 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.